Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher H Goss

Showing results (171-180 of 229) with videos related to

Pageof 23
Sort By:
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|September 7, 2023
Safety and Reactogenicity of COVID-19 Vaccination in Severe Alpha-1 Antitrypsin DeficiencyOliver J McElvaney, Brian Cleary, Daniel D Fraughen, et al.
Annals of the American Thoracic Society|April 25, 2026
Clinical effectiveness of elexacaftor/tezacaftor/ivacaftor (ETI) in People with Cystic Fibrosis in the United StatesGeorgene E Hergenroeder, Jonathan V Todd, Josh S Ostrenga, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|November 5, 2017
Lung function decline is delayed but not decreased in patients with cystic fibrosis and the R117H gene mutationJeffrey S Wagener, Stefanie J Millar, Nicole Mayer-Hamblett, et al.
American Journal of Respiratory and Critical Care Medicine|September 1, 2021
A Randomized Clinical Trial of Antimicrobial Duration for Cystic Fibrosis Pulmonary Exacerbation TreatmentChristopher H Goss, Sonya L Heltshe, Natalie E West, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 18, 2025
Evaluating the association of antibiotic spectrum and treatment responses of cystic fibrosis pulmonary exacerbationsRanjani Somayaji, Jonathan D Cogen, Donald VanDevanter, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 18, 2022
Health care costs in a randomized trial of antimicrobial duration among cystic fibrosis patients with pulmonary exacerbationsLaura S Gold, Ryan N Hansen, Donald L Patrick, et al.
Chest|April 20, 2021
Survival and Lung Transplant Outcomes for Individuals With Advanced Cystic Fibrosis Lung Disease Living in the United States and Canada: An Analysis of National RegistriesKathleen J Ramos, Jenna Sykes, Sanja Stanojevic, et al.
Critical Care Medicine|August 23, 2014
The burden of influenza-associated critical illness hospitalizationsJustin R Ortiz, Kathleen M Neuzil, David K Shay, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|November 12, 2022
Contemporary cystic fibrosis incidence rates in Canada and the United StatesAnne L Stephenson, Sana Swaleh, Jenna Sykes, et al.
Pediatric Pulmonology|September 18, 2024
A survey of cystic fibrosis physicians' views on lung transplant referral in the era of elexacaftor/tezacaftor/ivacaftorNora Burdis, Tijana Milinic, Lauren E Bartlett, et al.
Pageof 23

Showing results (171-180 of 229) with videos related to

Sort By:
Pageof 23
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|September 7, 2023
Safety and Reactogenicity of COVID-19 Vaccination in Severe Alpha-1 Antitrypsin DeficiencyOliver J McElvaney, Brian Cleary, Daniel D Fraughen, et al.
Annals of the American Thoracic Society|April 25, 2026
Clinical effectiveness of elexacaftor/tezacaftor/ivacaftor (ETI) in People with Cystic Fibrosis in the United StatesGeorgene E Hergenroeder, Jonathan V Todd, Josh S Ostrenga, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|November 5, 2017
Lung function decline is delayed but not decreased in patients with cystic fibrosis and the R117H gene mutationJeffrey S Wagener, Stefanie J Millar, Nicole Mayer-Hamblett, et al.
American Journal of Respiratory and Critical Care Medicine|September 1, 2021
A Randomized Clinical Trial of Antimicrobial Duration for Cystic Fibrosis Pulmonary Exacerbation TreatmentChristopher H Goss, Sonya L Heltshe, Natalie E West, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 18, 2025
Evaluating the association of antibiotic spectrum and treatment responses of cystic fibrosis pulmonary exacerbationsRanjani Somayaji, Jonathan D Cogen, Donald VanDevanter, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 18, 2022
Health care costs in a randomized trial of antimicrobial duration among cystic fibrosis patients with pulmonary exacerbationsLaura S Gold, Ryan N Hansen, Donald L Patrick, et al.
Chest|April 20, 2021
Survival and Lung Transplant Outcomes for Individuals With Advanced Cystic Fibrosis Lung Disease Living in the United States and Canada: An Analysis of National RegistriesKathleen J Ramos, Jenna Sykes, Sanja Stanojevic, et al.
Critical Care Medicine|August 23, 2014
The burden of influenza-associated critical illness hospitalizationsJustin R Ortiz, Kathleen M Neuzil, David K Shay, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|November 12, 2022
Contemporary cystic fibrosis incidence rates in Canada and the United StatesAnne L Stephenson, Sana Swaleh, Jenna Sykes, et al.
Pediatric Pulmonology|September 18, 2024
A survey of cystic fibrosis physicians' views on lung transplant referral in the era of elexacaftor/tezacaftor/ivacaftorNora Burdis, Tijana Milinic, Lauren E Bartlett, et al.
Pageof 23